Abstract
Background
The surgical community and the medical device industry enjoy a fruitful cooperation for the benefit of patients, but during the last years several high-risk products have led to problems and scandals, thus highlighting the need for reforms in European CE marking requirements. In October 2013, the European Parliament voted on a draft regulation on medical devices that intends to replace the current directives in 2014.
Purpose
This article offers guidance to surgeons on how to select and assess medical devices for clinical use. Examples include artificial sphincters, surgical meshes, as well as single-incision and robot-assisted surgery. It is important that surgeons have a basic understanding of the requirements for CE marking of new medical devices. Because device performance rather than effectiveness is required for European market entry, surgeons (and their patients) are often left with the burden of using potentially harmful devices. In addition, potential problems concerning the safety or effectiveness of approved devices are concealed by the lack of data transparency. Because regulatory reforms were blocked at the European level, many member states will now seek other ways of restricting the use of medical devices with unknown effectiveness. One interesting model in this regard is to link the reimbursement of new medical devices to the conduct of clinical trials.
Conclusions
Surgeons should develop a structured multidisciplinary approach to innovation management in their hospitals before using a new high-risk device. The key question is how to strike the right balance between innovation and safety.
Similar content being viewed by others
References
European Parliament (2013) Amendments adopted by the European Parliament on 22 October 2013 on the proposal for a regulation of the European Parliament and of the Council on medical devices, and amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009. http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2013-428 02 Accessed.January.2014
Hulstaert F, Neyt M, Vinck I, Stordeur S, Huic M, Sauerland S, Kuijpers MR, Abrishami P, Vondeling H, Van Brabandt H (2011) The pre-market clinical evaluation of innovative high-risk medical devices (KCE report 158C). Belgian Health Care Knowledge Centre, Brussels (Belgium)
Herrmann-Frank A, Lelgemann M (2013) Neue Medizinprodukte: Unzureichende Datenlage [New medical devices: insufficient evidence]. Dt Ärztebl 110(10):A432–A434
German National Associations of Statutory Health Insurance Funds (2013) Medical devices: the myths and the truth. http://www.aok-bv.de/imperia/md/aokbv/politik/versicherte/thesenpapier_gross_0913_engl_1.pdf.02 Accessed January 2014
Cohen D (2011) Out of joint: the story of the ASR. BMJ 342:d2905
Cohen D (2012) EU approval system leaves door open for dangerous devices. BMJ 345:e7173
Storz-Pfennig P, Schmedders M, Dettloff M (2013) Trials are needed before new devices are used in routine practice in Europe. BMJ 346:f1646
Kramer DB, Xu S, Kesselheim AS (2012) Regulation of medical devices in the United States and European Union. N Engl J Med 366(9):848–855
Curfman GD, Redberg RF (2011) Medical devices—balancing regulation and innovation. N Engl J Med 365(11):975–977
Kramer DB, Xu S, Kesselheim AS (2012) How does medical device regulation perform in the United States and the European Union? A systematic review. PLoS Med 9(7):e1001276
Krüger LJ, Wild C (2013) Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada (HTA Project Report No. 73). Ludwig Boltzmann Institute Health Technology Assessment, Vienna
Food and Drug Administration (FDA) (2012) Unsafe and ineffective devices approved in the EU that were not approved in the US. http://www.elsevierbi.com/∼/media/Supporting%20Documents/The%20Gray%20Sheet/38/20/FDA_EU_Devices_Report.pdf 02 Accessed January 2014
Anand R, Graves SE, de Steiger RN, Davidson DC, Ryan P, Miller LN, Cashman K (2011) What is the benefit of introducing new hip and knee prostheses? J Bone Joint Surg Am 93(Suppl 3):51–54
Lieberman JR, Wenger N (2004) New technology and the orthopaedic surgeon: are you protecting your patients? Clin Orthop Relat Res 429:338–341
Neugebauer EA, Becker M, Buess GF, Cuschieri A, Dauben HP, Fingerhut A, Fuchs KH, Habermalz B, Lantsberg L, Morino M, Reiter-Theil S, Soskuty G, Wayand W, Welsch T (2010) EAES recommendations on methodology of innovation management in endoscopic surgery. Surg Endosc 24(7):1594–1615
Selbmann HK (1997) Qualitäts—und Innovationsmanagement in der Chirurgie im Dienste des Patienten [Quality and innovation management in surgery for the patient’s benefit]. Langenbecks Arch Chir Suppl Kongressbd 114:872–879
Wright JG, Weinstein S (2013) The innovation cycle: a framework for taking surgical innovation into clinical practice. J Bone Joint Surg Am 95(21):e1641–e1645
Poulin P, Austen L, Kortbeek JB, Lafreniere R (2012) New technologies and surgical innovation: five years of a local health technology assessment program in a surgical department. Surg Innov 19(2):187–199
Hulstaert F, Neyt M, Vinck I, Stordeur S, Huic M, Sauerland S, Kuijpers MR, Abrishami P, Vondeling H, Flamion B, Garattini S, Pavlovic M, van Brabandt H (2012) Pre-market clinical evaluations of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care 28(3):278–284
Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G (2009) Informed consent: how much and what do patients understand? Am J Surg 198(3):420–435
McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK (2013) IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 346:f3012
Ergina PL, Barkun JS, McCulloch P, Cook JA, Altman DG (2013) IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ 346:f3011
Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A (2013) IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 346:f2820
McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, Nicholl J, Aronson JK, Barkun JS, Blazeby JM, Boutron IC, Clavien PA, Cook JA, Ergina PL, Feldman LS, Maddern GJ, Reeves BC, Seiler CM, Strasberg SM, Meakins JL, Ashby D, Black N, Bunker J, Burton M, Campbell M, Chalkidou K, Chalmers I, de Leval M, Deeks J, Grant A, Gray M, Greenhalgh R, Jenicek M, Kehoe S, Lilford R, Littlejohns P, Loke Y, Madhock R, McPherson K, Meakins J, Rothwell P, Summerskill B, Taggart D, Tekkis P, Thompson M, Treasure T, Trohler U, Vandenbroucke J (2009) No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374(9695):1105–1112
Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT (2000) Assessment of the learning curve in health technologies. A systematic review. Int J Technol Assess Health Care 16(4):1095–1108
McKinlay JB (1981) From “promising report” to “standard procedure”: seven stages in the career of a medical innovation. Milbank Mem Fund 59:374–411
Walters BC, Sackett DL (1991) Why clinical research? In: Troidl H, Spitzer WO, McPeek B et al (eds) Principle and practice of research: strategies for surgical investigators, 2nd edn. Springer, New York, pp 231–248
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (2011) Allgemeine Methoden: Version 4.0. https://www.iqwig.de/download/IQWiG_Methoden_Version_4_0.pdf.02 Accessed January 2014
Samore MH, Evans RS, Lassen A, Gould P, Lloyd J, Gardner RM, Abouzelof R, Taylor C, Woodbury DA, Willy M, Bright RA (2004) Surveillance of medical device-related hazards and adverse events in hospitalized patients. JAMA 291(3):325–334
Cooper MA, Ibrahim A, Lyu H, Makary MA (2013) Underreporting of robotic surgery complications. J Healthc Qual
Fuller J, Ashar BS, Carey-Corrado J (2005) Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA. J Minim Invasive Gynecol 12(4):302–307
Ansaloni L, Catena F, Coccolini F, Negro P, Campanelli G, Miserez M (2009) New “biological” meshes: the need for a register. The EHS registry for biological prostheses: call for participating European surgeons. Hernia 13(1):103–108
Arezzo A, Zornig C, Mofid H, Fuchs KH, Breithaupt W, Noguera J, Kaehler G, Magdeburg R, Perretta S, Dallemagne B, Marescaux J, Copaescu C, Graur F, Szasz A, Forgione A, Pugliese R, Buess G, Bhattacharjee HK, Navarra G, Godina M, Shishin K, Morino M (2013) The EURO-NOTES clinical registry for natural orifice transluminal endoscopic surgery: a 2-year activity report. Surg Endosc 27(9):3073–3084
Tunis SR, Pearson SD (2006) Coverage options for promising technologies: Medicare’s ‘coverage with evidence development’. Health Aff (Millwood) 25(5):1218–1230
Daniel GW, Rubens EK, McClellan M (2013) Coverage with evidence development for medicare beneficiaries: challenges and next steps. JAMA Intern Med 173(14):1281–1282
Ates M, Dirican A, Ince V, Ara C, Isik B, Yilmaz S (2012) Comparison of intracorporeal knot-tying suture (polyglactin) and titanium endoclips in laparoscopic appendiceal stump closure: a prospective randomized study. Surg Laparosc Endosc Percutan Tech 22(3):226–231
Markar SR, Karthikesalingam A, Di Franco F, Harris AM (2013) Systematic review and meta-analysis of single-incision versus conventional multiport appendicectomy. Br J Surg 100(13):1709–1718
Geng L, Sun C, Bai J (2013) Single incision versus conventional laparoscopic cholecystectomy outcomes: a meta-analysis of randomized controlled trials. PLoS One 8(10):e76530
Saad S, Strassel V, Sauerland S (2013) Randomized clinical trial of single-port, minilaparoscopic and conventional laparoscopic cholecystectomy. Br J Surg 100(3):339–349
Maggiori L, Gaujoux S, Tribillon E, Bretagnol F, Panis Y (2012) Single-incision laparoscopy for colorectal resection: a systematic review and meta-analysis of more than a thousand procedures. Colorectal Dis 14(10):e643–e654
Gregor S, Maegele M, Sauerland S, Krahn J, Peinemann F, Lange S (2008) Negative pressure wound therapy: a vacuum of evidence? Arch Surg 143(2):189–196
Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP (2012) Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev 4:Cd009261
Mees ST, Palmes D, Mennigen R, Senninger N, Haier J, Bruewer M (2008) Endo-vacuum assisted closure treatment for rectal anastomotic insufficiency. Dis Colon Rectum 51(4):404–410
Bonavina L, Saino G, Bona D, Sironi A, Lazzari V (2013) One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg 217(4):577–585
Ganz RA, Peters JH, Horgan S, Bemelman WA, Dunst CM, Edmundowicz SA, Lipham JC, Luketich JD, Melvin WS, Oelschlager BK, Schlack-Haerer SC, Smith CD, Smith CC, Dunn D, Taiganides PA (2013) Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 368(8):719–727
Wong MT, Meurette G, Stangherlin P, Lehur PA (2011) The magnetic anal sphincter versus the artificial bowel sphincter: a comparison of 2 treatments for fecal incontinence. Dis Colon Rectum 54(7):773–779
Wong MT, Meurette G, Wyart V, Lehur PA (2012) Does the magnetic anal sphincter device compare favourably with sacral nerve stimulation in the management of faecal incontinence? Colorectal Dis 14(6):e323–e329
Rodriguez L, Rodriguez P, Gomez B, Ayala JC, Saba J, Perez-Castilla A, Galvao Neto M, Crowell MD (2013) Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trial. Surg Endosc 27(4):1083–1092
Thin NN, Horrocks EJ, Hotouras A, Palit S, Thaha MA, Chan CL, Matzel KE, Knowles CH (2013) Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br J Surg 100(11):1430–1447
Zechmeister-Koss I, Huic M, Fischer S (2013) Duodenal-jejunal bypass sleeve for the treatment of obesity with or without type II diabetes mellitus (EUnetHTA final report). http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/Endobarrier_Assessment.pdf.02 Accessed January 2014
Slater NJ, van der Kolk M, Hendriks T, van Goor H, Bleichrodt RP (2013) Biologic grafts for ventral hernia repair: a systematic review. Am J Surg 205(2):220–230
Contin P, Goossen K, Grummich K, Jensen K, Schmitz-Winnenthal H, Büchler MW, Diener MK (2013) ENERgized vessel sealing systems versus CONventional hemostasis techniques in thyroid surgery—the ENERCON systematic review and network meta-analysis. Langenbecks Arch Surg 398(8):1039–1056
Wang Z, Zheng Q, Jin Z (2012) Meta-analysis of robot-assisted versus conventional laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. ANZ J Surg 82(3):112–117
Cirocchi R, Boselli C, Santoro A, Guarino S, Covarelli P, Renzi C, Listorti C, Trastulli S, Desiderio J, Coratti A, Noya G, Redler A, Parisi A (2013) Current status of robotic bariatric surgery: a systematic review. BMC Surg 13(1):53
Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH (2013) Robotic versus laparoscopic versus open gastrectomy: a meta-analysis. J Gastric Cancer 13(3):136–148
Acknowledgments
The authors thank Natalie McGauran for editorial support.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sauerland, S., Brockhaus, A.C., Fujita-Rohwerder, N. et al. Approaches to assessing the benefits and harms of medical devices for application in surgery. Langenbecks Arch Surg 399, 279–285 (2014). https://doi.org/10.1007/s00423-014-1173-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-014-1173-y